(Alliance News) - RTW Biotech Opportunities Ltd on Friday noted that portfolio firm BioAge Labs Inc has completed a USD198 million initial public offering.

BioAge Labs stock rose Thursday on the company's upsized IPO — reflecting enthusiasm for its approach to obesity treatments.

London, UK-based Vicebio raised $100 million in a Series B that will help to fund the development of its Molecular Clamp ...

Biotech IPOs are on the rise as interest rates fall, signaling a potential recovery for the sector. Read more here.

In the HY primary two issues were priced totaling US$1.2bn, lifting weekly supply to US$9.195bn and September volume to US$36.625bn, according to IFR data. The average IG bond spread was unchanged at ...

The target of the strike in Lebanon was the group’s leader, Hassan Nasrallah, according to Israeli and American officials. The attack came shortly after the Israeli prime minister gave a defiant ...

The veteran lawmaker also submitted public comment to the Food and Drug Administration as… The number of outbreaks and people sick in them in the Netherlands has gone down compared to the ...

The Democrat faces five criminal charges and could face decades in prison if found guilty. Environmentcategory Hurricane Helene hits Florida as one of the largest storms to strike US 5:03 AM UTC ...

Former Canadian politician suspected of working for foreign government: CSIS Former Canadian politician suspected of working for foreign government: CSIS Canada’s intelligence community released ...

ChatGPT vs. Google Gemini: Which Chatbot Wins?

The size of the IPO is estimated to be around $1.25 billion, but this could increase before the launch, according to bankers. Swiggy's revenue grew by 33% to Rs 11,634 crore in FY24, with net losses ...